Advanced Technologies & Treatments for Diabetes, Amsterdam, 19–22 March 2025
Authors:
Adriana Ilavská
Authors‘ workplace:
Medispektrum s. r. o., Bratislava
Published in:
Diab Obez 2025; 25(1): 64-65
Category:
News
Labels
Diabetology ObesitologyArticle was published in
Diabetes and obesity
2025 Issue 1
-
All articles in this issue
- Editoriál
- Experience with the management of patients with extreme obesity – Part 2
- Tirzepatide – a dual incretin agonist in the management of type 2 diabetes mellitus: a review of evidence from the SURPASS trials
- Efficacy and safety of canagliflozin – a brief overview of the results of relevant clinical studies (meta-analyses and network analyses)
- Physical activity with a hybrid closed-loop system
- The addictive potential and the neurobiological mechanisms underlying the consumption of hyperpalatable foods: Does food addiction exist?
- Mild autonomous cortisol secretion from a diabetologist's point of view
- How should we proceed today with primary prevention of cardiovascular disease – data affects women
- Patients with T2DM without present CVD but with already present risk CV-factors: case reports
- Metformin XR – possible causes of intolerance
- 20 years of the Diabetology Education Center in Martin
- 7th National SDS Symposium: Where are we moving with technology in diabetes in Slovakia
- Interdisciplinary Dialogue on the Treatment of Cardio-metabolic Syndrome (31 January – 1 February 2025, Bratislava): report
- Advanced Technologies & Treatments for Diabetes, Amsterdam, 19–22 March 2025
- MUDr. Michaela Važanová – portrét ambulantnej diabetologičky
- MUDr. Viliam Vaník – portrét ambulantného diabetóga
- Diabetes and obesity
- Journal archive
- Current issue
- About the journal
Most read in this issue
- Tirzepatide – a dual incretin agonist in the management of type 2 diabetes mellitus: a review of evidence from the SURPASS trials
- The addictive potential and the neurobiological mechanisms underlying the consumption of hyperpalatable foods: Does food addiction exist?
- Patients with T2DM without present CVD but with already present risk CV-factors: case reports
- Editoriál